BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Treprostinil (Orenitram) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Treprostinil (Orenitram)\, from ClinicalT
 rials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07112183-11039@assetmemo.bio
DTSTAMP:20261121T004114Z
DTSTART;VALUE=DATE:20280930
DTEND;VALUE=DATE:20281001
SUMMARY:Treprostinil (Orenitram): Phase 4 readout est. (NCT07112183)
DESCRIPTION:Treprostinil (Orenitram)\, phase 4.\nStudy: Open Label Treprost
 inil Raynaud's Study\nEstimated primary completion: 30 September 2028. Thi
 s is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it
  can move.\nDrug page: https://assetmemo.bio/drug/treprostinil-orenitram#u
 pcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT07112
 183
URL:https://assetmemo.bio/drug/treprostinil-orenitram#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
